eClinical Solutions Market

The global eClinical solutions market is projected to reach USD 31.32 billion by 2031, growing from USD 15.80 billion in 2026, at a CAGR of 14.7% from 2026 to 2031. There is an increasing trend of complexity and regulations in clinical trials, which is propelling the adoption of eClinical solutions. The pharma, biotechnology organizations, contract research organizations, and academic sponsors are increasingly utilizing technologies such as EDC, CTMS, eCOA/ePRO, clinical trial supplies, safety data, and analytics for improving the efficacy of clinical trials, enhancing data integrity, conducting remote/decentralized trials, and adhering to regulations. Furthermore, the growth in the number of clinical trials being conducted, an increase in investments for research and development activities from pharmaceutical and biotechnology companies, a favorable funding scenario for clinical research, and the need for integrated data are fuelling the growth of the market.

ClinicalTrials.gov has more than 585,000 registered studies from 226 different countries and territories, indicating the magnitude and complexity of international clinical research. In the European Union, the CTIS system has become an important resource for clinical trial registration and approval. EMA stated that nearly 4,000 trials with made decisions were made publicly available in June ‘24, and 500 new clinical trials per month would be added to the CTIS website. Such trends will create a rising need for platforms able to handle submissions, document management, data entry, monitoring, and reporting in a compliant and scalable manner. Nevertheless, growth potential might be limited by relatively high costs associated with integration, lack of clinical data management and regulation technology specialists, data security issues, as well as low market awareness.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in the eClinical solutions market include Medidata (Dassault Systèmes) (US), Veeva Systems (US), IQVIA (US), ICON Plc (Ireland), Oracle (US), among others. These companies adopted strategies such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the eClinical solutions market.

In October ‘24, Medidata launched Medidata Rave Lite, which simplifies data collection and management, enabling research teams to conduct trials efficiently while ensuring compliance with regulatory standards. Similarly, in November ‘24, Medidata and Bioforum strengthened their partnership to improve data management, optimize trial efficiency, and support the development of innovative treatments.

Medidata (Dassault Systèmes) has made a solid position in the eClinical solutions industry by providing a full range of services for conducting clinical studies worldwide through clinical data capture, trial management, analytics, and clinical study execution. Many features included in Medidata’s offering help in dealing with different types of clinical study requirements. Medidata continuously develops by innovating, focusing on creating clinical trial technology products based on AI and integration. In May ‘25, Medidata rolled out Medidata Protocol Optimization, which is an AI-based solution developed by Medidata for designing clinical trials as part of the Study Experience product line. The solution uses machine learning models along with aggregated data from earlier clinical trials to predict the results of clinical trials, optimize clinical trial designs, streamline patient enrolment processes, and reduce workloads at sites and for patients. However, Medidata does not only concentrate on innovation within its company but also makes partnerships and collaborations.

Veeva Systems is one of the leading providers of industry-specific cloud solutions to the global life science industry. The company specializes in delivering cloud-based software and data solutions along with business consulting services designed specifically for the unique requirements of pharmaceutical, biotech, and medical device companies through their entire lifecycle from research and development to the commercialization stage. The company’s solutions help life science companies speed up the product development and commercialization process and ensure that they comply with all regulations. In terms of financial reporting, Veeva classifies its revenues into two broad groups: Commercial Solutions and R&D Solutions. Some examples of Commercial Solutions include Veeva Commercial Cloud and Veeva Claims Solutions, whereas some R&D Solutions include Veeva Development Cloud, Veeva RegulatoryOne and Veeva QualityOne. Veeva Development Cloud includes several applications for clinical, regulatory, quality and safety departments.

IQVIA has a strong presence across the healthcare and life sciences industry and is widely recognized for its expertise in clinical research, real-world evidence, data analytics, and commercial outsourcing services. The company continues to expand its eClinical solutions portfolio to strengthen its competitive position and support sponsors in managing increasingly complex clinical trials. IQVIA’s technology-enabled and decentralized trial capabilities help improve data quality, enhance patient experience, increase trial accessibility, and reduce study timelines. Its position in the eClinical solutions market is further supported by strategic collaborations, acquisitions, and continued investment in R&D and digital clinical technologies. In addition, IQVIA’s global operating footprint, including key markets such as China, India, Japan, Turkey, and other emerging regions, enables the company to support multinational clinical trials and broaden access to its integrated clinical development solutions.

In February ’26, IQVIA and Duke Clinical Research Institute announced a strategic collaboration to accelerate clinical research innovation and improve evidence generation capabilities. The collaboration combines IQVIA’s analytics, AI, and clinical technology infrastructure with DCRI’s academic research expertise to support more efficient trial design, operational execution, and real-world evidence development across global clinical studies.

Market Ranking

Leading companies operating in the eClinical solutions market include Medidata (Dassault Systèmes), Veeva Systems, IQVIA, ICON plc, Oracle, Signant Health, and Clario (Thermo Fisher Scientific Inc.). These companies are providing integrated platforms that enable pharmaceuticals, biotechnology companies, CROs, and academic research organizations to capture, analyze, manage, and report clinical data, manage decentralized clinical trials, manage regulatory documents, manage patient engagement and interactions, and comply with regulations while conducting clinical trials. Such players have gained significant market share in the eClinical solutions industry owing to their extensive range of products, capability to implement systems across several countries, large customer base, and capability to support complex, multinationals trials. Moreover, the presence of specialized providers of eClinical solutions such as eClinical Solutions LLC, Clinion, MaxisIT, 4G Clinical, Fountayn, Saama, Suvoda LLC, Advarra, Caidya, OpenClinica LLC, EvidentIQ, Ennov, and Perceptive is adding more strength to the competitive structure by focusing on electronic data capture, clinical data management, randomization and trial supply management, eCOA/ePRO, clinical trial oversight, regulatory document management, AI-driven analytics, and site support, among others.

Related Reports:

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Analytics), Phase, Trial (Decentralized), Therapy (Onco, Cardio, Neuro, Rare Disease), End User (CRO, Pharma & Biotech) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]